| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 25 May 2024 | 16 May 2024 |
| Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Saturday 25th May 2024 at registered office of the company inter alia to consider following business. 1. Approve and take on record the Audited Standalone Financial Results of the Company for the quarter and year ended on 3pt March 2024. 2. Any other matter which the Board may think fit. Please take the above intimation in your records. Thanking You. Audited Financial Results for the Quarter and Year Ended on 31st March, 2024 Outcome of the Board Meeting held on 25th May 2024. (As Per BSE Announcement Dated on 25.05.2024) | ||
| Board Meeting | 22 Jan 2024 | 16 Jan 2024 |
| Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Monday January 22 2024 inter alia to approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 31st December 2023 also transact other business activities. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company met in their meeting held on today i.e. Monday 22nd January 2024 . 1.) Considered and approved Un-audited financial results for the quarter ended as on 31st December 2023. The meeting commenced at 04.15 P.M. and concluded at 04.45 P.M. Kindly take the same on your record and oblige. Thanking You PFA (As per BSE Announcement Dated on 22/01/2024) PFA (As per BSE Announcement Dated on 13/02/2024) | ||
| Board Meeting | 9 Jan 2024 | 3 Jan 2024 |
| Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/01/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Tuesday January 92024 inter alia to consider the appointment and Resignation of Director. Please take the above intimation in your records. Thanking You. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company held today 09th January 2024 inter alia, and consider following businesses. 1. Ms. Chhaya Parmar is appointed as non-executive independent director of the company w e f. 09.01.2024 subject to approval of members. 2. The board has considered and accepted the resignation of Independent Director Ms Manjula Parmar w e.f 09.01.2024. The board meeting started at 12.30 P.M. and concluded at 01.00. P M. Please take the same on your record. (As Per BSE Announcement Dated on 09.01.2024) PFA (As Per BSE Announcement dated on 10.01.2024) | ||
| Board Meeting | 1 Nov 2023 | 26 Oct 2023 |
| Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve Notice pursuant to regulation 29 of SEBI (LODR) Regulation 2015 be and is hereby given that the meeting of the Board of Directors of the Company will be held on Wednesday November 1 2023 inter alia to consider the Un-Audited financial results of the company for quarter and half year ended on September 30 2023 and also transact other business activities. Please take the above intimation in your records. Thanking you. | ||
| Board Meeting | 10 Aug 2023 | 3 Aug 2023 |
| Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that a meeting of the Board of Directors of the Company will be held on Thursday 10th August 2023 inter alia to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended on 30th June 2023. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You. Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Thursday 10th August 2023 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2023. The board meeting concluded on 05.00. P.M. Please take the above intimation in your records. Thanking You, (As Per BSE Announcement Dated on 10.08.2023) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
